{"filing":{"accession_number":"0001213900-26-086773","cik":"0001468492","ticker":"HSCSW","company_name":"HeartSciences Inc.","form":"8-K","filing_date":"2026-08-07","report_date":"2026-08-04","primary_document":"ea0301173-8k_heart.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1468492/000121390026086773/ea0301173-8k_heart.htm"},"events":[{"id":25129,"run_id":22800,"accession_number":"0001213900-26-086773","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"HeartSciences received a Nasdaq notice on August 4, 2026, that it failed to comply with Listing Rule 5550(b)(1), which requires a minimum of $2,500,000 in stockholders' equity. The company reported only $226,060 in stockholders' equity as of April 30, 2026, and does not meet alternative compliance metrics. Nasdaq has provided 45 days to submit a compliance plan, with potential delisting if the company fails to regain compliance. This is a classic delisting-risk disclosure under Item 3.01.","company_name":"HeartSciences Inc.","ticker":"HSCSW","filing_date":"2026-08-07","form":"8-K","submitted_at":null,"items":[{"id":25882,"accession_number":"0001213900-26-086773","item_number":"3.01","item_title":"Notice of Delisting or Failure","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"HeartSciences received a Nasdaq notice on August 4, 2026, that it failed to comply with Listing Rule 5550(b)(1), which requires a minimum of $2,500,000 in stockholders' equity. The company reported only $226,060 in stockholders' equity as of April 30, 2026, and does not meet alternative compliance metrics. Nasdaq has provided 45 days to submit a compliance plan, with potential delisting if the company fails to regain compliance. This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T00:31:44.240363+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":25882,"accession_number":"0001213900-26-086773","item_number":"3.01","item_title":"Notice of Delisting or Failure","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"HeartSciences received a Nasdaq notice on August 4, 2026, that it failed to comply with Listing Rule 5550(b)(1), which requires a minimum of $2,500,000 in stockholders' equity. The company reported only $226,060 in stockholders' equity as of April 30, 2026, and does not meet alternative compliance metrics. Nasdaq has provided 45 days to submit a compliance plan, with potential delisting if the company fails to regain compliance. This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T00:31:44.240363+00:00","company_name":"HeartSciences Inc.","ticker":"HSCSW","filing_date":"2026-08-07"}]}